<SEC-DOCUMENT>0000905148-25-003282.txt : 20250903
<SEC-HEADER>0000905148-25-003282.hdr.sgml : 20250903
<ACCEPTANCE-DATETIME>20250903164315
ACCESSION NUMBER:		0000905148-25-003282
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250903
DATE AS OF CHANGE:		20250903

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIODESIX INC
		CENTRAL INDEX KEY:			0001439725
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				203986492
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-91818
		FILM NUMBER:		251290479

	BUSINESS ADDRESS:	
		STREET 1:		919 WEST DILLON ROAD
		CITY:			LOUISVILLE
		STATE:			CO
		ZIP:			80027
		BUSINESS PHONE:		303-417-0500

	MAIL ADDRESS:	
		STREET 1:		919 WEST DILLON ROAD
		CITY:			LOUISVILLE
		STATE:			CO
		ZIP:			80027

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SCHULER JACK W
		CENTRAL INDEX KEY:			0001021412
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	MAIL ADDRESS:	
		STREET 1:		PO BOX 531
		CITY:			LAKE BLUFF
		STATE:			IL
		ZIP:			60044
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13D" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>SCHEDULE 13D/A</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001021412</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>



</filerInfo>
</headerData>
<formData>
<coverPageHeader>
<amendmentNo>8</amendmentNo>
<securitiesClassTitle>Common Stock, par value $0.001 per share</securitiesClassTitle>
<dateOfEvent>08/29/2025</dateOfEvent>
<previouslyFiledFlag>false</previouslyFiledFlag>
<issuerInfo>
<issuerCIK>0001439725</issuerCIK>
<issuerCUSIP>09075X108</issuerCUSIP>
<issuerName>BIODESIX INC</issuerName>
<address>
<com:street1>919 WEST DILLON RD</com:street1>
<com:city>LOUISVILLE</com:city>
<com:stateOrCountry>CO</com:stateOrCountry>
<com:zipCode>80027</com:zipCode>
</address>
</issuerInfo>
<authorizedPersons>
<notificationInfo>
<personName>Jack W. Schuler</personName>
<personPhoneNum>(520) 906-2991</personPhoneNum>
<personAddress>
<com:street1>PO Box 531</com:street1>
<com:city>Lake Bluff</com:city>
<com:stateOrCountry>IL</com:stateOrCountry>
<com:zipCode>60044</com:zipCode>
</personAddress>
</notificationInfo>
</authorizedPersons>
</coverPageHeader>
<reportingPersons>
<reportingPersonInfo>
<reportingPersonCIK>0001021412</reportingPersonCIK>
<reportingPersonName>SCHULER JACK W</reportingPersonName>
<fundType>PF</fundType>
<citizenshipOrOrganization>X1</citizenshipOrOrganization>
<soleVotingPower>414811</soleVotingPower>
<sharedVotingPower>39406546</sharedVotingPower>
<soleDispositivePower>414811</soleDispositivePower>
<sharedDispositivePower>39406546</sharedDispositivePower>
<aggregateAmountOwned>39821357</aggregateAmountOwned>
<isAggregateExcludeShares>N</isAggregateExcludeShares>
<percentOfClass>26</percentOfClass>
<typeOfReportingPerson>IN</typeOfReportingPerson>
<commentContent>(1) Sole voting and dispositive power includes 414,811 Shares (as defined herein) that the Reporting Person has the right to acquire within 60 days of the date of this filing.&#13;
&#13;
(2) Percent of class is calculated based on a total of 152,721,438 Shares outstanding, as provided by the Issuer on September 3, 2025, plus 414,811 Shares that the Reporting Person has the right to acquire within 60 days of the date of this filing.</commentContent>
</reportingPersonInfo>
<reportingPersonInfo>
<reportingPersonNoCIK>Y</reportingPersonNoCIK>
<reportingPersonName>Jack W. Schuler Living Trust</reportingPersonName>
<fundType>WC</fundType>
<citizenshipOrOrganization>IL</citizenshipOrOrganization>
<soleVotingPower>0</soleVotingPower>
<sharedVotingPower>24406546</sharedVotingPower>
<soleDispositivePower>0</soleDispositivePower>
<sharedDispositivePower>24406546</sharedDispositivePower>
<aggregateAmountOwned>24406546</aggregateAmountOwned>
<isAggregateExcludeShares>N</isAggregateExcludeShares>
<percentOfClass>16</percentOfClass>
<typeOfReportingPerson>OO</typeOfReportingPerson>
<commentContent>(1) Percent of class is calculated based on a total of 152,721,438 Shares outstanding, as provided by the Issuer on September 3, 2025.</commentContent>
</reportingPersonInfo>
<reportingPersonInfo>
<reportingPersonNoCIK>Y</reportingPersonNoCIK>
<reportingPersonName>Jack W. Schuler 2025 GRAT</reportingPersonName>
<fundType>WC</fundType>
<citizenshipOrOrganization>IL</citizenshipOrOrganization>
<soleVotingPower>0</soleVotingPower>
<sharedVotingPower>15000000</sharedVotingPower>
<soleDispositivePower>0</soleDispositivePower>
<sharedDispositivePower>15000000</sharedDispositivePower>
<aggregateAmountOwned>15000000</aggregateAmountOwned>
<isAggregateExcludeShares>N</isAggregateExcludeShares>
<percentOfClass>9.8</percentOfClass>
<typeOfReportingPerson>OO</typeOfReportingPerson>
<commentContent>(1) Percent of class is calculated based on a total of 152,721,438 Shares outstanding, as provided by the Issuer on September 3, 2025.</commentContent>
</reportingPersonInfo>
</reportingPersons>
<items1To7>
<item1>
<securityTitle>Common Stock, par value $0.001 per share</securityTitle>
<issuerName>BIODESIX INC</issuerName>
<issuerPrincipalAddress>
<com:street1>919 WEST DILLON RD</com:street1>
<com:city>LOUISVILLE</com:city>
<com:stateOrCountry>CO</com:stateOrCountry>
<com:zipCode>80027</com:zipCode>
</issuerPrincipalAddress>
<commentText>This Amendment No. 8 to Schedule 13D ("Amendment No. 8") is being filed by the undersigned, pursuant to section 240.13d-2(a), to amend and supplement the Schedule 13D filed with the U.S. Securities and Exchange Commission (the "SEC") on November 9, 2020 (the "Initial Schedule 13D"), as amended on January 28, 2022, on April 11, 2022, on November 23, 2022, on August 11, 2023, on April 9, 2024, on May 23, 2024, and on May 20, 2025 (collectively, the "Schedule 13D"), with respect to the common stock, par value $0.001 per share (the "Shares"), of Biodesix, Inc. (the "Issuer" or the "Company"), whose principal executive offices are located at 919 West Dillon Rd., Louisville, Colorado 80027.</commentText>
</item1>
<item2>
<principalBusinessAddress>Item 2(b) of the Schedule 13D is hereby amended and restated in its entirety as follows:&#13;
&#13;
The principal address of each of the Reporting Persons is PO Box 531, Lake Bluff, Illinois 60044.</principalBusinessAddress>
</item2>
<item3>
<fundsSource>Item 3 of the Schedule 13D is hereby amended and supplemented as follows:&#13;
&#13;
On August 29, 2025, Mr. Schuler, through the Trust, purchased 3,488,372 Shares, at a price of $0.43 per Share, in a registered at-the-market offering, for an aggregate purchase price of $1,499,999.96.&#13;
&#13;
The source of funds for the purchase reported herein was Mr. Schuler's personal funds.</fundsSource>
</item3>
<item5>
<percentageOfClassSecurities>Item 5(a)-(c) of the Schedule 13D is hereby amended and restated as follows:&#13;
&#13;
As of the date hereof, Mr. Schuler may be deemed to beneficially own, in the aggregate, 39,821,357 Shares, which represents approximately 26.0% of the Shares outstanding.&#13;
&#13;
Mr. Schuler's beneficial ownership consists of (i) 83,152 Shares that Mr. Schuler has the right to acquire upon exercise of options exercisable within 60 days of the date of this filing, (ii) 331,659 Shares that Mr. Schuler has the right to acquire upon settlement of vested RSUs within 60 days of the date of this filing, (iii) 24,406,546 Shares held by the Trust, representing approximately 16.0% of the Shares outstanding, and (iv) 15,000,000 Shares held by the GRAT, representing approximately 9.8% of the Shares outstanding.&#13;
&#13;
The foregoing beneficial ownership percentages are based on a total of (i) 152,721,438 Shares outstanding, as provided by the Issuer on September 3, 2025, and, for purposes of calculating Mr. Schuler's beneficial ownership percentage, (ii) 414,811 Shares that Mr. Schuler has the right to acquire within 60 days of the date of this filing.</percentageOfClassSecurities>
<numberOfShares>Mr. Schuler has the sole power to vote or direct the vote, and the sole power to dispose or direct the disposition of, the 414,811 Shares that Mr. Schuler has the right to acquire within 60 days of the date of this filing.&#13;
&#13;
As sole trustee of the Trust, Mr. Schuler shares with the Trust the power to vote or direct the vote, and the power to dispose or direct the disposition of, the 24,406,546 Shares beneficially owned by the Trust.&#13;
&#13;
As sole trustee of the GRAT, Mr. Schuler shares with the GRAT the power to vote or direct the vote, and the power to dispose or direct the disposition of, the 15,000,000 Shares beneficially owned by the GRAT.</numberOfShares>
<transactionDesc>The response to Item 3 of this Amendment No. 8 is incorporated by reference herein. Except as set forth in this Amendment No. 8, no transactions in the Shares have been effected by the Reporting Persons within the past 60 days.</transactionDesc>
</item5>
</items1To7>
<signatureInfo>
<signaturePerson>
<signatureReportingPerson>SCHULER JACK W</signatureReportingPerson>
<signatureDetails>
<signature>/s/ Jack W. Schuler</signature>
<title>Jack W. Schuler</title>
<date>09/03/2025</date>
</signatureDetails>
</signaturePerson>
<signaturePerson>
<signatureReportingPerson>Jack W. Schuler Living Trust</signatureReportingPerson>
<signatureDetails>
<signature>/s/ Jack W. Schuler</signature>
<title>Jack W. Schuler, Trustee</title>
<date>09/03/2025</date>
</signatureDetails>
</signaturePerson>
<signaturePerson>
<signatureReportingPerson>Jack W. Schuler 2025 GRAT</signatureReportingPerson>
<signatureDetails>
<signature>/s/ Jack W. Schuler</signature>
<title>Jack W. Schuler, Trustee</title>
<date>09/03/2025</date>
</signatureDetails>
</signaturePerson>
</signatureInfo>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
